125 related articles for article (PubMed ID: 7346837)
21. Carnitine therapy... Let the patients benefit!
Roberto L; Ingram J; Lynch E; Okupinski V; Bushman M
Nephrol Nurs J; 2005; 32(1):91-3. PubMed ID: 15787092
[No Abstract] [Full Text] [Related]
22. [Lipid metabolism and lipid utilization in renal failure].
Druml W; Laggner A; Lenz K; Balcke P; Kleinberger G; Schmidt P
Infusionsther Klin Ernahr; 1983 Aug; 10(4):206-12. PubMed ID: 6618660
[No Abstract] [Full Text] [Related]
23. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
Reuter SE; Faull RJ; Ranieri E; Evans AM
Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
[TBL] [Abstract][Full Text] [Related]
24. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients.
Alhomida AS
Arch Med Res; 1997; 28(1):101-7. PubMed ID: 9078596
[TBL] [Abstract][Full Text] [Related]
25. Dialysis-related carnitine disorder.
Hedayati SS
Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
[TBL] [Abstract][Full Text] [Related]
26. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
Thompson CH; Irish AB; Kemp GJ; Taylor DJ; Radda GK
Clin Nephrol; 1997 Jun; 47(6):372-8. PubMed ID: 9202867
[TBL] [Abstract][Full Text] [Related]
27. Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients.
Biolo G; Stulle M; Bianco F; Mengozzi G; Barazzoni R; Vasile A; Panzetta G; Guarnieri G
Nephrol Dial Transplant; 2008 Mar; 23(3):991-7. PubMed ID: 18045815
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of orally supplemented L-carnitine in premature infants receiving Intralipid 20%.
Curran JS; Williams PR; Kanarek KS; Novak M; Monkus EF
Acta Chir Scand Suppl; 1983; 517():157-64. PubMed ID: 6587688
[No Abstract] [Full Text] [Related]
29. Improved lipid profiles with bicarbonate dialysis.
Ahmad S; Haas L; Pagel M; Sherrard D
Proc Clin Dial Transplant Forum; 1980; 10():186-9. PubMed ID: 7346846
[No Abstract] [Full Text] [Related]
30. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis.
Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L
Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772
[TBL] [Abstract][Full Text] [Related]
31. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P
Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329
[TBL] [Abstract][Full Text] [Related]
32. Carnitine: a false dawn in the treatment of muscle weakness in end-stage renal failure patients?
Davenport A
Nephron Clin Pract; 2004; 97(2):c33-4. PubMed ID: 15218327
[No Abstract] [Full Text] [Related]
33. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
Suzuki A; Sakai Y; Hashimoto K; Osawa H; Tsuruoka S
Ren Fail; 2018 Nov; 40(1):196-200. PubMed ID: 29616582
[TBL] [Abstract][Full Text] [Related]
34. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
35. Hyperlipidemia in patients with chronic renal failure.
Ravichandran R; Nerurkar SV; Acharya VN; Taskar SP
J Postgrad Med; 1983 Oct; 29(4):212-7. PubMed ID: 6672179
[No Abstract] [Full Text] [Related]
36. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
[TBL] [Abstract][Full Text] [Related]
37. [Levels of L-carnitine in serum of patients with chronic renal failure treated by hemodialysis (HD)].
Wanic-Kossowska M; Bombicki K; Kozioł L; Czarnecki R
Pol Arch Med Wewn; 1998 Apr; 99(4):314-22. PubMed ID: 9760819
[TBL] [Abstract][Full Text] [Related]
38. Cholesterol metabolism in patients with chronic renal failure on hemodialysis.
Igel-Korcagova A; Raab P; Brensing KA; Pöge U; Klehr HU; Igel M; von Bergmann K; Sudhop T
J Nephrol; 2003; 16(6):850-4. PubMed ID: 14736012
[TBL] [Abstract][Full Text] [Related]
39. [The efficacy of the substitution of carnivit in patients with chronic failure treated with hemodialysis].
Wanic-Kossowska M; Piszczek I; Rogacka D; Czarnecki R; Kozioł L; Czekalski S
Pol Arch Med Wewn; 1999 Oct; 102(4):885-91. PubMed ID: 10948713
[TBL] [Abstract][Full Text] [Related]
40. Carnitine replacement in end-stage renal disease and hemodialysis.
Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
